UnitedHealth Group Incorporated $UNH Stock: UNIVEST FINANCIAL Corp Reduces Stake

UNIVEST FINANCIAL Corp decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 13.4% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 41,580 shares of the healthcare conglomerate’s stock after selling 6,454 shares during the period. UnitedHealth Group comprises approximately 0.7% of UNIVEST FINANCIAL Corp’s investment portfolio, making the stock its 27th biggest holding. UNIVEST FINANCIAL Corp’s holdings in UnitedHealth Group were worth $15,263,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. Machina Capital S.A.S. bought a new position in UnitedHealth Group in the third quarter worth about $7,497,000. DSG Capital Advisors LLC boosted its holdings in shares of UnitedHealth Group by 0.9% in the 3rd quarter. DSG Capital Advisors LLC now owns 62,565 shares of the healthcare conglomerate’s stock valued at $22,966,000 after buying an additional 568 shares in the last quarter. Silver Grove Financial Group Inc. grew its position in shares of UnitedHealth Group by 5.7% in the 3rd quarter. Silver Grove Financial Group Inc. now owns 1,165 shares of the healthcare conglomerate’s stock worth $428,000 after buying an additional 63 shares during the last quarter. Illinois Municipal Retirement Fund raised its stake in shares of UnitedHealth Group by 7.8% during the 3rd quarter. Illinois Municipal Retirement Fund now owns 61,044 shares of the healthcare conglomerate’s stock worth $22,408,000 after acquiring an additional 4,395 shares in the last quarter. Finally, Bahl & Gaynor LLC raised its stake in shares of UnitedHealth Group by 3.9% during the 3rd quarter. Bahl & Gaynor LLC now owns 1,187,519 shares of the healthcare conglomerate’s stock worth $435,915,000 after acquiring an additional 44,364 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have weighed in on the stock. DA Davidson set a $512.00 target price on shares of UnitedHealth Group in a research note on Tuesday, July 21st. Wells Fargo & Company reduced their price target on UnitedHealth Group from $526.00 to $487.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 27th. The Goldman Sachs Group increased their price objective on UnitedHealth Group from $435.00 to $490.00 and gave the company a “buy” rating in a report on Friday, July 17th. New Street Research set a $402.00 price objective on UnitedHealth Group in a research report on Friday, October 9th. Finally, Cantor Fitzgerald boosted their target price on UnitedHealth Group from $440.00 to $495.00 and gave the stock an “overweight” rating in a research note on Friday, July 17th. Twenty research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $463.93.

Insider Buying and Selling at UnitedHealth Group

In other news, CEO Patrick Conway sold 1,169 shares of the firm’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the transaction, the chief executive officer directly owned 15,328 shares in the company, valued at $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 0.19% of the company’s stock.

UnitedHealth Group Trading Down 0.5%

NYSE:UNH opened at $403.14 on Thursday. UnitedHealth Group Incorporated has a 12 month low of $255.96 and a 12 month high of $461.62. The firm has a fifty day simple moving average of $391.12 and a 200-day simple moving average of $364.76. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.66. The company has a market capitalization of $361.22 billion, a P/E ratio of 23.02, a PEG ratio of 1.47 and a beta of 0.51.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.14 by $0.55. The firm had revenue of $112.72 billion for the quarter, compared to the consensus estimate of $111.31 billion. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The firm’s revenue was down .4% on a year-over-year basis. During the same period in the prior year, the firm earned $2.59 EPS. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 20.61 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Monday, December 7th will be paid a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a yield of 2.3%. The ex-dividend date is Monday, December 7th. UnitedHealth Group’s payout ratio is presently 53.00%.

UnitedHealth Group Company Profile

UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.